Histogen Announces $5M Private Placement Priced At-The-Market Under Nasdaq Rules
Histogen Inc. (NASDAQ:HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious and
Kaspien Holdings Announces Pricing of $8M Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
Kaspien Holdings Inc. (or the "Company") (NASDAQ:KSPN), a leading e-commerce marketplace growth platform, today announced that it has entered into a securities purchase agreement with a single institutional
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
American Rebel Raises $13M Via Equity Offering
American Rebel Holdings Inc (NASDAQ:AREB) has entered into a securities purchase agreement with a single institutional investor to raise about $13.0…